Hypervision Surgical

Hypervision Surgical

Private
LondonHealthcare & Life Scienceshttps://hypervisionsurgical.com

Last Round

Series A

Apr 29, 2026

Total Funding Raised

$31.38M

Momentum Score

25 /100

Company Overview

Hypervision Surgical is a MedTech company that develops an AI-powered hyperspectral imaging platform for real-time, data-driven tissue analysis to improve surgical precision and patient safety.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Medical AI, Medical Imaging, Computer Vision

Business Model

B2B

Customer Profile

Hardware Sales, Hardware + Subscription, Government Contracts

AI Layer

Application

Keywords

hyperspectral imagingHSIsurgical AIreal-time tissue analysissurgical imagingsurgical decision supportintraoperative imagingcomputer-assisted surgerydigital surgerytissue viability assessmentmedical imaging AIdye-free imagingsurgical computer visiontissue oxygenationrobotic surgery integrationmedical device

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Hypervision Surgical Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Hypervision Surgical Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series AApr 29, 2026
GrantOct 1, 2024
SeedJun 1, 2023
GrantMar 9, 2023
GrantFeb 17, 2021

Key People

Founding team and executive leadership

Tom Vercauteren

Co-Founder And Chief Scientific Officer (CSO)

Founding Team

Michael Ebner

CEO Co-Founder

Founding Team

Jaco Jacobs

Chief Operating Officer

Executive Team

Hypervision Surgical Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 29, 2026

    Tanja Dowe joins the Board of Directors.

  • Apr 29, 2026

    $23M round led by Heal Capital.

Hypervision Surgical Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Hypervision Surgical Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Hypervision Surgical's valuation, stock price, and market status.

Firmographic Details

HeadquartersLondon
Employee Range25
Year Founded2020
Last FundingApr 29, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.